10 AstraZeneca AI and data science leaders
Oncology accounts for two of these AstraZeneca AI leaders, one in clinical development and one in precision oncology; the others cover the Centre for Artificial Intelligence, AI services and platforms, enterprise AI process, computational pathology, Early CVRM data science, AI in care, AI research and AI partnerships. Three are executive directors, six senior directors, a fit for a drug developer deciding whether AI belongs in research, the clinic or a shared enterprise team.
Professionals to explore
Anouk Veldman, MSc
LinkedInExperience: Senior Director, Head of AI Global BioPharma Transform Care · AstraZeneca
$1,010 per 30-minute call
Two current AstraZeneca titles belong to Anouk Veldman, MSc: Senior Director, Head of AI Global BioPharma Transform Care since 2026 and Global Director of Digital Precision Healthcare since 2023. Veldman was also Global Lead Digital Health Strategy - Turbu+ program (2016-2023) and Global Lead Patient Support Strategy (2014-2015) there, a record suited to questions on AI and digital tools in patient care.
Is this you? Claim your profile and get paid for calls.
Christos Matsoukas
LinkedInExperience: Director of Artificial Intelligence · AstraZeneca
$808 per 30-minute call
Christos Matsoukas, in Stockholm, became Director of Artificial Intelligence at AstraZeneca in 2026, and was Associate Director, Artificial Intelligence there from 2025 to 2026. Matsoukas also held a Researcher title at AstraZeneca (2018-2024) and was an AI Research Scientist at KTH Royal Institute of Technology (2024-2025), which fits questions on taking AI research into a pharma research setting.
Is this you? Claim your profile and get paid for calls.
Gerald J. Sun
LinkedInExperience: Senior Director, Head of AI for Clinical Development, Oncology · AstraZeneca
$1,010 per 30-minute call
Gerald J. Sun took the title Senior Director, Head of AI for Clinical Development, Oncology at AstraZeneca in 2026, a group lead role for the oncology portfolio's clinical development with an "AI-forward" approach. Sun's other AstraZeneca titles were Director, Multimodal AI Research (2025-2026), Associate Director, Applied Data Science (2022-2025) and Senior Data Scientist (2018-2022), a fit for questions on AI in oncology trials.
Is this you? Claim your profile and get paid for calls.
Hebe Middlemiss
LinkedInExperience: Former Executive Director, AI Enterprise Process & Innovation · AstraZeneca
$1,211 per 30-minute call
Since 2026, Hebe Middlemiss has been Executive Director, AI Enterprise Process & Innovation at AstraZeneca, described as "Leading AI transformation across the AstraZeneca enterprise." Middlemiss held Senior Director, AI Strategy & Innovation (2024-2026), Director, AI Product & Strategy (2022-2024) and Associate Director, AI Product (2022) there, so questions on AI product strategy and enterprise rollout fit.
Is this you? Claim your profile and get paid for calls.
Ian Henry
LinkedInExperience: Senior Director, Head of Data Science and Artificial Intelligence, Early CVRM · AstraZeneca
$1,010 per 30-minute call
For Early CVRM, Ian Henry has been Senior Director, Head of Data Science and Artificial Intelligence at AstraZeneca since 2020, a role described as creating and delivering a data science and AI strategy for Early CVRM and building an international team. Henry was Head of Bioinformatics and Scientific Data Services at Scionics Computer Innovation GmbH (2010-2020) and Scientific Computing Facility Leader at MPI-CBG (2012-2020).
Is this you? Claim your profile and get paid for calls.
James Savery
LinkedInExperience: Senior Director – AI Partnerships and Data Governance · AstraZeneca
$1,010 per 30-minute call
As Senior Director – AI Partnerships and Data Governance at AstraZeneca since 2026, James Savery says the focus moved to AI partnerships "After leading the internal ML/AI delivery team" as Senior Director - Machine Learning & AI (2022-2026). Savery was a Principal Scientist at AstraZeneca (2019-2021) and at MedImmune (2017-2019), so questions on outside AI partners and data governance fit.
Is this you? Claim your profile and get paid for calls.
Kausar Begam Riaz Ahmed
LinkedInExperience: Senior Director, Head of AI Precision Oncology · AstraZeneca
$1,010 per 30-minute call
Kausar Begam Riaz Ahmed has held the title Senior Director, Head of AI Precision Oncology at AstraZeneca since 2026. Riaz Ahmed was also Director, Generative AI Medical Engagement Lead (2024-2026) and Director, Group Lead (2023-2024) at Pfizer and Senior Science Advisor at the FDA (2021-2023), which suits questions on generative AI in medical engagement and on the regulator's side, given the FDA role.
Is this you? Claim your profile and get paid for calls.
Marta Tolos
LinkedInExperience: Executive Director, Group Head of AI Services and Platforms · AstraZeneca
$1,346 per 30-minute call
Marta Tolos, based in Barcelona, is Executive Director, Group Head of AI Services and Platforms at AstraZeneca, current since 2024, and describes a team of AI engineers across the UK, USA, Spain, Mexico and India working on "the development and deployment of AI Enterprise Services and Platforms." At Zurich Insurance, Tolos was Senior Director, Head of Data Science & Data Engineering (2021-2024) and Director, Head of Big Data Analytics Delivery (2016-2021), and also teaches as an adjunct professor.
Is this you? Claim your profile and get paid for calls.
Nicolas Brieu
LinkedInExperience: Senior Director - Head of CP Computer Vision & AI · AstraZeneca
$943 per 30-minute call
Nicolas Brieu, based in the Munich area, is Senior Director - Head of CP Computer Vision & AI at AstraZeneca, current since 2025, in what their LinkedIn profile calls AstraZeneca Computational Pathology. Brieu held Director - Head of CP Computer Vision & AI (2024-2025) and Director - Team lead, Imaging AI (2022-2024) there, and was Principal Software Engineer / Team lead at Brainlab (2020-2022), so imaging AI questions fit best.
Is this you? Claim your profile and get paid for calls.
Tom Diethe
LinkedInExperience: Executive Director, Head of the Centre for Artificial Intelligence · AstraZeneca
$1,346 per 30-minute call
Tom Diethe has been Executive Director, Head of the Centre for Artificial Intelligence at AstraZeneca since 2023, a centre that by its own description works to "build cutting edge AI systems." Diethe's earlier record includes Applied Science Manager: Machine Learning at Amazon (2017-2023), Machine Learning Researcher at Microsoft (2013-2014) and Machine Learning Consultant at BMJ Publishing Group (2011-2012), useful for comparing central AI teams in tech and pharma.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For an enterprise-wide AI operating model, talk to one of the three executive directors: Tom Diethe, Marta Tolos or Hebe Middlemiss. For AI inside a therapy area or a scientific workflow, Gerald J. Sun, Kausar Begam Riaz Ahmed, Ian Henry and Nicolas Brieu hold the therapy area and scientific workflow roles, while James Savery is the one to ask about AI partnerships and data governance and Anouk Veldman about AI in patient care.
Questions to take into the conversation
- 01How do you decide which AI work a pharma company's central AI centre owns and which stays inside oncology or other therapy area teams?
- 02What does it take to move a computer vision model for pathology slides from research into routine use in drug development?
- 03How should a drugmaker set up data governance and outside partnerships when it buys or co-develops AI models?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.